PeriVision SA
PeriVision SA develops AI, virtual reality, and cloud-based platforms for efficient and accessible eye testing, focusing on glaucoma and retinal diseases.
About
PeriVision SA is a Swiss medtech company specializing in innovative eye care solutions that combine artificial intelligence, virtual reality, and cloud technology. The company develops products to address challenges in eye care, such as the growing prevalence of vision impairment, by making eye testing more accessible, portable, and efficient. PeriVision's flagship platform, VisionOne, enables portable, cloud-based visual field testing and analysis, particularly focused on glaucoma diagnosis and monitoring. Their solutions are clinically validated and developed in collaboration with leading clinics, eye doctors, and patients. PeriVision drives clinical insight, improves workflow efficiency, and enhances patient experiences while making eye care accessible globally.
Products & Services
- VisionOne VR visual field platform
- AI-optimized eye test algorithms (including patented SORS)
- Cloud-based technician and clinician dashboards for scheduling, configuring, and analyzing eye tests
- VR-based perimetry for glaucoma diagnosis and monitoring
- Eye tracking and virtual assistant for patient guidance
- Testing software subscriptions for clinics and practices
- Partnership research in functional eye tests for retinal diseases (e.g., AMD, diabetic retinopathy)
- At-home vision testing systems for clinical trials and patient monitoring
Use Cases & Case Studies
- Portable and resource-efficient visual field testing in clinics
- At-home glaucoma monitoring and clinical trial participation
- Improved workflow and reduced technician time for eye testing
- Accessibility of visual field tests for patients with mobility issues
- Community-based glaucoma assessment in Scotland (NESGAT)
- Functional testing for patients with AMD and diabetic retinopathy
- Acceptance, tolerability, and comfort studies for home-based VR perimetry
Partnerships & Collaborations
- University of Bern (ARTORG Center for Biomedical Engineering)
- University Hospital Bern / Inselspital
- NHS Scotland (NES Glaucoma Award Training)
- Von Hoff AG (ophthalmology distributor for Switzerland & Liechtenstein)
- EIT Health (accelerator and funding)
- Foundation for Technological Innovation (FIT funding)
Awards & Recognition
- CE-mark for VisionOne (EU)
- FDA registration (US)
- EIT Health Wild Card accelerator winner (2021)
- Biopôle Start-up Fund recipient
- CHF 1.1 M grant for retinal disease research (with University of Bern/Inselspital)
- Innosuisse Certificate for investment readiness
- FIT Tech Seed Loan (CHF 100,000)
- SOI 2022 award for Chief Commercial Officer's service to ophthalmology
Contact Information
Certifications & Compliance
- CE-mark (Europe)
- FDA registration (United States)
- Planned UK MHRA compliance
- Swiss engineering and clinical data compliance